Results 11 to 20 of about 323,234 (402)

Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke

open access: yesStroke, 2021
Thrombi retrieved from patients with acute ischemic stroke are highly heterogeneous. Recent data suggest that thrombus composition may impact on mechanical thrombectomy, the number of recanalization manoeuvres, resistance to retrieval, and on ...
Precious Jolugbo, R. Ariëns
semanticscholar   +1 more source

Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association

open access: yesCirculation, 2022
Despite the many advances in cardiovascular medicine, decisions concerning the diagnosis, prevention, and treatment of left ventricular (LV) thrombus often remain challenging. There are only limited organizational guideline recommendations with regard to
G. Levine   +10 more
semanticscholar   +1 more source

Thrombus or Tumor ?

open access: yesClinical Case Reports, 2023
Key clinical messageContrast defects in veins are often diagnosed as benign thrombi, but depending on the patient’s background it is necessary to differentiate between tumor thrombi. It is difficult to differentiate between these using contrast‐enhanced CT alone, but with angioscopy it is easy to visually distinguish between a benign and tumor thrombi ...
Shiho Wakasa   +4 more
openaire   +3 more sources

Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing

open access: yesGenome Biology, 2022
Background Vascular invasion with tumor thrombus frequently occurs in advanced renal cell carcinoma (RCC). Thrombectomy is one of the most challenging surgeries with high rate of perioperative morbidity and mortality.
Yue Shi   +10 more
semanticscholar   +1 more source

Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first‐line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study

open access: yesCancer, 2021
The efficacy and safety of transarterial chemoembolization (TACE) plus lenvatinib in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) have not been evaluated.
Xiaoyan Ding   +9 more
semanticscholar   +1 more source

Thrombus Structural Composition in Cardiovascular Disease

open access: yesArteriosclerosis, Thrombosis and Vascular Biology, 2021
Thrombosis is a major complication of cardiovascular disease, leading to myocardial infarction, acute ischemic stroke, or venous thromboembolism. Thrombosis occurs when a thrombus forms inside blood vessels disrupting blood flow.
G. Alkarithi   +4 more
semanticscholar   +1 more source

Thrombectomy in Acute Ischemic Stroke: Challenges to Procedural Success [PDF]

open access: yesJournal of Stroke, 2017
The overwhelming clinical benefit of intra-arterial stroke therapy owes to the major advance in revascularization brought on by the current generation of thrombectomy devices.
Albert J. Yoo, Tommy Andersson
doaj   +1 more source

Central venous catheter-related superior vena cava syndrome following renal transplantation -A case report- [PDF]

open access: yesKorean Journal of Anesthesiology, 2012
A 55-year-old man with end-stage renal disease had severe left ventricular dysfunction and a history of deep vein thrombosis. He underwent renal transplantation, during which a central venous catheter was inserted into the right jugular vein. The central
Misook Seo, Won-Jung Shin, In-Gu Jun
doaj   +1 more source

Elaborately Engineering a Self‐Indicating Dual‐Drug Nanoassembly for Site‐Specific Photothermal‐Potentiated Thrombus Penetration and Thrombolysis

open access: yesAdvancement of science, 2021
Thrombotic cardio‐cerebrovascular diseases seriously threaten human health. Currently, conventional thrombolytic treatments are challenged by the low utilization, inferior thrombus penetration, and high off‐target bleeding risks of most thrombolytic ...
Zhiqiang Zhao   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy